ArcticZymes Technologies ASALTS:0DRV 77 Current Ratio is 15.83 as of Mar. 2026, which is 44% above its 10-year median of 11.02. GuruFocus rates LTS:0DRV with a GF Score™ of 77/100 and a GF Value™ of kr23.85 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,412 Biotechnology companies, ArcticZymes Technologies ASA ranks better than 87.68% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. ArcticZymes Technologies ASA's current ratio for the quarter that ended in Mar. 2026 was 15.83.
ArcticZymes Technologies ASA has a current ratio of 15.83. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for ArcticZymes Technologies ASA's Current Ratio or its related term are showing as below:
LTS:0DRV'
s Current Ratio Range Over the Past 10 Years
Min: 2.5 Med: 11.02 Max: 18.03
Current: 15.83
During the past 13 years, ArcticZymes Technologies ASA's highest Current Ratio was 18.03. The lowest was 2.50. And the median was 11.02.
LTS:0DRV's Current Ratio is ranked better than 87.68% of 1412
companies
in the Biotechnology industry
Industry Median: 3.9
vs LTS:0DRV: 15.83
ArcticZymes Technologies ASA (LTS:0DRV) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
ArcticZymes Technologies ASA Current Ratio Related Terms
ArcticZymes Technologies ASA Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DRV vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Current Ratio distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (LTS:0DRV) has a Current Ratio of 15.83 as of Mar. 2026. This is 44% above median its historical median of 11.02. Over the past decade, ArcticZymes Technologies ASA's Current Ratio has ranged from 2.50 to 18.03. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #174 out of 1412 companies in the Biotechnology industry, placing it in the top 12.3%.
Is ArcticZymes Technologies ASA's Current Ratio too high?
ArcticZymes Technologies ASA's current Current Ratio of 15.83 is 44% above median its 10-year median of 11.02. Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 18.03. The Biotechnology industry median Current Ratio is 3.90. ArcticZymes Technologies ASA's value of 15.83 is 305.9% above this industry median. Based on the distribution chart, ArcticZymes Technologies ASA ranks #174 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #174 out of 1412 companies for Current Ratio. This places ArcticZymes Technologies ASA in the top 12% of its industry — outperforming the majority of peers. The industry median Current Ratio is 3.90. ArcticZymes Technologies ASA's value of 15.83 is 305.9% above this benchmark. Historically, ArcticZymes Technologies ASA's own Current Ratio has ranged from 2.50 to 18.03 over the past decade. While the company's 10-year median is 11.02 vs. the industry median of 3.90, ArcticZymes Technologies ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.90, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ArcticZymes Technologies ASA's current Current Ratio of 15.83 is 305.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current Current Ratio is 15.83, which is 44% above median its own 10-year median of 11.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.85, compared to a current price of kr20.90 — trading 12.4% below its estimated fair value. The current Current Ratio is 15.83, which is 44% above median its 10-year median of 11.02 and 305.9% above the Biotechnology industry median of 3.90. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Current Ratio is 15.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of kr20.90 is trading 12.4% below its estimated GF Value™ of kr23.85.
GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.
Key valuation signals for LTS:0DRV:
Current Ratio: 15.83 (44% above median its 10-year median of 11.02)
GF Value™: kr23.85 vs. price of kr20.90 (12.4% below fair value)
Industry Position: 305.9% above the Biotechnology median (#174 of 1412)
No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score
Get the complete analysis for LTS:0DRV
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRV has been successfully added to your 
